Researchers at the University of Texas at Dallas found that estrogen cream did not reduce the risk of relapse in women after pelvic organ prolapse surgery. published research Journal of the American Medical Association (JAMA).
Pelvic organ prolapse is a condition in which weakening of the muscles and other tissues in the pelvis causes one or more organs, including the uterus, bladder, and rectum, to fall below their normal position. Most of the time, women with this disease do not have any symptoms and do not need treatment. But sometimes sagging can cause discomfort, urine leakage, and pain during exercise or sex. More severe cases may require surgery, but about 12% of women over 65 will need re-operation within five years.
At the onset of menopause, the level of estrogen hormone drops, which causes thinning of the vaginal tissue. It was believed that estrogen used before and after surgery would help strengthen the thinning vaginal tissue and reduce the likelihood of recurrence of sagging.
In the new study, researchers analyzed data from 186 postmenopausal women who had surgery for sagging. Half were prescribed estrogen vaginal cream at least five weeks before surgery, followed by a placebo cream for the remainder for a year.
The use of vaginal estrogen cream before and after the procedure did not reduce the risk of recurrence of sagging. One year after surgery, 19% of women using estrogen cream had a relapse, and 9% of women using a placebo cream (inactive) had a relapse.
But the cream has been shown to reduce dryness and pain during sex, so women with these symptoms may benefit from the cream. This drug has contraindications, including breast cancer and thrombosis, so hormones should be used after consulting a doctor.
ancient scientists removed The myth of high testosterone in women.